Medicare aims to address industry pain points such as pharmaceutical counterfeiting, information opacity, and centralized operations, bridging traditional centralized information and achieving drug traceability and data sharing in the pharmaceutical industry under the premise of information security and confidentiality. In the Medicare project system, the information of each link in the supply chain's drug circulation to the market is recorded in the chain after third-party identification. The data is reliable, tamperproof, and easily traceable, ensuring the safety and reliability of the final drug traceability throughout the entire supply chain, and ensuring the safety of medical drugs....